Lupin receives USFDA approval for generic Liraglutide Injection and Glucagon, expanding access to diabetes treatments.

Mumbai: Global pharma major Lupin Limited has received approval from the United States Food and Drug Administration (USFDA) ...

The new implant contains a reservoir of glucagon that sits beneath the skin and can be activated in an emergency, with no need for injections. For individuals with Type 1 diabetes, the risk of ...

Vertex Pharmaceuticals' new therapy, zimislecel, has potential to be a "functional cure," experts say. A new stem cell ...

Hypoglycemia, or low blood sugar, is a potentially dangerous condition that’s most common in people with diabetes. Learn more here.

Hormones can impact every body system. Growth hormones and even insulin imbalances may even play a role in penis size and function.

MIT researchers develop a wireless implant that detects low blood sugar and releases glucagon, offering a potential safety ...